Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

983 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunosuppression as a risk factor for COVID-19: a meta-analysis.
Tassone D, Thompson A, Connell W, Lee T, Ungaro R, An P, Ding Y, Ding NS. Tassone D, et al. Among authors: an p. Intern Med J. 2021 Feb;51(2):199-205. doi: 10.1111/imj.15142. Intern Med J. 2021. PMID: 33631862 Free PMC article.
Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China.
An P, Ji M, Ren H, Su J, Ding NS, Kang J, Yin A, Zhou Q, Shen L, Zhao L, Jiang X, Xiao Y, Tan W, Lv X, Li J, Liu S, Zhou J, Chen H, Xu Y, Liu J, Chen M, Cao J, Zhou Z, Shen L, Tan S, Yu H, Dong W, Ding Y. An P, et al. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525-527. doi: 10.1016/S2468-1253(20)30121-7. Epub 2020 Apr 17. Lancet Gastroenterol Hepatol. 2020. PMID: 32311321 Free PMC article. No abstract available.
Prevention of COVID-19 in patients with IBD - Authors' reply.
Ding NS, An P, Dong W, Ding Y. Ding NS, et al. Among authors: an p. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):640-641. doi: 10.1016/S2468-1253(20)30156-4. Lancet Gastroenterol Hepatol. 2020. PMID: 32553142 Free PMC article. No abstract available.
Gastrointestinal Symptoms Onset in COVID-19 Patients in Wuhan, China.
An P, Chen H, Ren H, Su J, Ji M, Kang J, Jiang X, Yang Y, Li J, Lv X, Yin A, Chen D, Chen M, Zhou Z, Dong W, Ding Y, Yu H. An P, et al. Dig Dis Sci. 2021 Oct;66(10):3578-3587. doi: 10.1007/s10620-020-06693-6. Epub 2020 Nov 12. Dig Dis Sci. 2021. PMID: 33180244 Free PMC article.
Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease.
Ren H, Kang J, Wang J, Su J, Zou L, Yin A, Li J, Zhou Q, Wang W, Tang Z, Zhang J, Lu Y, Yang Y, Qiu C, Ding Y, Dong W, An P. Ren H, et al. Among authors: an p. Inflamm Bowel Dis. 2024 Aug 1;30(8):1295-1302. doi: 10.1093/ibd/izad184. Inflamm Bowel Dis. 2024. PMID: 37619248
RESULTS: Compared with the standard group, 2 initial intravenous injections of ustekinumab achieved higher clinical response (92.2%, 47 of 51, P = .656), clinical remission (88.2%, 45 of 51, P = .221), endoscopic response (75.8%, 25 of 33, P = .125), and FC n …
RESULTS: Compared with the standard group, 2 initial intravenous injections of ustekinumab achieved higher clinical response (92.2%, 47 of 5 …
An education-based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study).
Kang J, Su J, Wang J, Ren H, Yin A, Li J, Zhou Q, Wang Y, Zhu P, Zou L, Wang W, Tang Z, Dong W, Ding Y, An P. Kang J, et al. Among authors: an p. United European Gastroenterol J. 2023 Dec;11(10):960-972. doi: 10.1002/ueg2.12470. Epub 2023 Nov 3. United European Gastroenterol J. 2023. PMID: 37921707 Free PMC article.
983 results